Edwards lifts FY26 growth outlook following steady Q2 performance
Edwards TAVR business contributed the lion’s share of its Q2 revenues at $1.26bn, largely informing its decision to uplift its…
Edwards TAVR business contributed the lion’s share of its Q2 revenues at $1.26bn, largely informing its decision to uplift its…
Thermo’s Q2 performance was driven by its laboratory products and biopharma services business with profits around $6.69bn equating to a…
Edwards TAVR business contributed the lion’s share of its Q2 revenues at $1.26bn, largely informing its decision to uplift its…
Thermo’s Q2 performance was driven by its laboratory products and biopharma services business with profits around $6.69bn equating to a…
The platform is intended for use by dental professionals, dental service organisations, and imaging centres.
The study aims to assess the safety, efficacy and device performance of the Venus-PowerX in severe aortic stenosis patients.
Upon completion of the SCS neuromodulation implant procedure, the chronic pain 18-year-old Ralph Seed had experienced for the past five…
Prima is intended for individuals whose central vision loss has previously restricted their ability to read or recognise faces.
Under the agreement, bioAffinity’s sputum analysis will be combined with Pictor’s proteomic platform to analyse inflammation.
The AHA’s Impact Report was created using independent clinical and image data through its AI Assessment Lab.
While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with…
Remote patient monitoring (RPM) is a fast-growing market in healthcare and will mean more support from your medical engineering partner…